Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus-Reference-Cited by-同舟云学术

Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus

Published:2016-06 Issue:6 Volume:17 Page:e231-e239
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Schmiegelow Kjeld,Attarbaschi Andishe,Barzilai Shlomit,Escherich Gabriele,Frandsen Thomas Leth,Halsey Christina,Hough Rachael,Jeha Sima,Kato Motohiro,Liang Der-Cherng,Mikkelsen Torben Stamm,Möricke Anja,Niinimäki Riitta,Piette Caroline,Putti Maria Caterina,Raetz Elizabeth,Silverman Lewis B,Skinner Roderick,Tuckuviene Ruta,van der Sluis Inge,Zapotocka Ester

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. Childhood acute lymphoblastic leukemia: progress through collaboration;Pui;J Clin Oncol,2015

2. Chronic health conditions in adult survivors of childhood cancer;Oeffinger;N Engl J Med,2006

3. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort;Essig;Lancet Oncol,2014

4. Inherited genetic variation in childhood acute lymphoblastic leukemia;Moriyama;Blood,2015

5. Development of a reliable and valid system for classifying treatment-related mortality in children with cancer;Alexander;Lancet Oncol,2015

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Potential Role of Phytopharmaceuticals in Alleviating Toxicities of Chemotherapeutic Agents;Current Protein & Peptide Science;2024-12

2. Upregulation of Insulin-like Growth Factor-I in Response to Chemotherapy in Children with Acute Lymphoblastic Leukemia;International Journal of Molecular Sciences;2024-09-04

3. Hepatic veno-occlusive disease with asparaginase products: a review of cases reported to the FDA adverse event reporting system and published in the literature;Pediatric Hematology and Oncology;2024-08-28

4. Exploring cell-derived extracellular vesicles in peripheral blood and bone marrow of B-cell acute lymphoblastic leukemia pediatric patients: proof-of-concept study;Frontiers in Immunology;2024-08-21

5. A Refined Population Pharmacokinetic Model–Based Guideline for Individualized PEGasparaginase Dosing in Pediatric Acute Lymphoblastic Leukemia;Therapeutic Drug Monitoring;2024-08-13